Cambridge Open Engage home
What is Cambridge Open Engage?
How to Submit
Browse
About
News [opens in a new tab]

Occurrence and Distribution of Pharmaceuticals and their Transformation Products in Luxembourgish Surface Waters

11 May 2021, Version 1
Working Paper
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

This pre-print describes the analysis of pharmaceuticals and their transformation products in surface water samples collected in Luxembourg from 2019 to 2020. Details of the experimental and computational tools and workflows used are fully described in the manuscript. Links to the suspect lists, codes used, and data files are also provided.

Keywords

pharmaceuticals
surface water
suspect screening
HRMS
transformation products
cheminformatics
open source
non-target screening

Supplementary weblinks

Title
Description
Actions
Title
Description
Actions
View
Title
Description
Actions
View
Title
Description
Actions
View
Title
Description
Actions
View
Title
Description
Actions
View
Title
Description
Actions
View
Title
Description
Actions
View
Title
Description
Actions
View

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.

Version History

May 11, 2021 Version 1

Metrics

1,036
281
0
Views
Downloads
Citations

License

CC logo
CC
BY logo
BY
The content is available under CC BY 4.0 [opens in a new tab]

DOI

10.26434/chemrxiv.14564301.v1
D O I: 10.26434/chemrxiv.14564301.v1 [opens in a new tab]

Funding

Luxembourg National Research Fund (FNR) project A18/BM/12341006

Author’s competing interest statement

The authors declare no competing financial interest.

Share